GNH USA

Europe — EMA

Лабама

Лабама (Fulvestrant) is an estrogen receptor antagonist used in hormone receptor-positive breast cancer therapy. This intramuscular injection provides targeted

Fulvestrant

Request sourcing

1
Pack/s

What is Fulvestrant?

Лабама (Fulvestrant) is an estrogen receptor antagonist used in hormone receptor-positive breast cancer therapy. This intramuscular injection provides targeted hormonal treatment for postmenopausal women with advanced or metastatic disease. Fulvestrant works by blocking estrogen receptors to slow tumor growth.

What is Fulvestrant used for?

Fulvestrant is prescribed for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. It is used when prior endocrine therapy has not been effective or when disease progression occurs during treatment. Fulvestrant is also indicated for postmenopausal women with advanced breast cancer not previously treated with endocrine therapy. This medication helps manage symptoms and slow disease progression by blocking estrogen receptors in cancer cells.

What are the side effects of Fulvestrant?

Fulvestrant is administered as an intramuscular injection and may take several weeks to show noticeable effects. Patients often experience stabilization of disease rather than immediate symptom relief. Common effects include injection site reactions, such as pain or redness, which typically resolve over time. Some individuals may notice improved energy levels or reduced disease-related symptoms as treatment progresses.

What precautions apply to Fulvestrant?

This medication should only be handled and administered by healthcare professionals. Patients should inform their doctor about any allergies, liver conditions, or bleeding disorders before starting fulvestrant. Regular monitoring of liver function and blood counts is recommended during treatment. Patients should avoid activities requiring alertness until they understand how fulvestrant affects them.

What does Fulvestrant interact with?

Fulvestrant may interact with blood thinners such as warfarin, requiring close monitoring of blood clotting levels. Certain medications, including CYP3A4 inhibitors, may affect how fulvestrant is processed in the body. Patients should inform their doctor about all prescription, over-the-counter, and herbal medications they are taking. Alcohol use should be discussed with a healthcare provider before starting treatment.

Frequently asked questions

What is fulvestrant used for?+
Fulvestrant is used to treat hormone receptor-positive metastatic breast cancer in postmenopausal women.
How is fulvestrant administered?+
Fulvestrant is given as an intramuscular injection, typically in the buttock area.
What are common side effects of fulvestrant?+
Common effects include injection site reactions like pain or redness, and potential changes in liver function.
Can fulvestrant be taken with other medications?+
Fulvestrant may interact with certain medications; patients should inform their doctor about all current medications.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Fulvestrant
Route
Intramuscular Use
Manufacturer
Gedeon Richter Plc.
Origin
EU

Related products